Penumbra (PEN) Enterprise Value (2014 - 2026)
Penumbra's (PEN) quarterly Enterprise Value came in at -$615.7 million in Q1 2026, down 62.51% year-on-year from -$1.6 billion in Q1 2025, and down 13.0% on a QoQ basis from -$544.8 million in Q4 2025.
Penumbra (PEN) Enterprise Value (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Enterprise Value data on file, last reported at -$615.7 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 62.51% year-over-year to -$615.7 million in Q1 2026; TTM through Mar 2026 was -$615.7 million, a 62.51% decrease from a year earlier, with the FY2025 full-year figure at -$544.8 million, down 60.18% from the prior year.
- Enterprise Value for Q1 2026 stood at -$615.7 million, down from -$544.8 million in the prior quarter.
- Over the last five years, Enterprise Value for PEN reached as high as -$184.4 million in Q3 2022 and fell as low as -$615.7 million in Q1 2026.
- Historically, Enterprise Value has averaged -$323.2 million across 5 years, with a median of -$291.0 million in 2024.
- Across the five-year window, Enterprise Value jumped 32.48% in 2022 and plunged 62.51% in 2026, its largest moves.
- Year by year, Enterprise Value stood at -$188.0 million in 2022, then tumbled by 53.8% to -$289.2 million in 2023, then slipped by 17.62% to -$340.1 million in 2024, then slumped by 60.18% to -$544.8 million in 2025, then dropped by 13.0% to -$615.7 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$615.7 million in Q1 2026, -$544.8 million in Q4 2025, and -$470.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -3.09 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -577.00 Mn |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn | -615.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -615.66 Mn |
| Dec 31, 2025 | -544.82 Mn |
| Sep 30, 2025 | -470.30 Mn |
| Jun 30, 2025 | -424.56 Mn |
| Mar 31, 2025 | -378.85 Mn |
| Dec 31, 2024 | -340.13 Mn |
| Sep 30, 2024 | -291.02 Mn |
| Jun 30, 2024 | -339.70 Mn |
| Mar 31, 2024 | -313.47 Mn |
| Dec 31, 2023 | -289.19 Mn |
| Sep 30, 2023 | -248.86 Mn |
| Jun 30, 2023 | -221.06 Mn |
| Mar 31, 2023 | -199.10 Mn |
| Dec 31, 2022 | -188.03 Mn |
| Sep 30, 2022 | -184.43 Mn |
| Jun 30, 2022 | -204.37 Mn |
| Mar 31, 2022 | -240.34 Mn |
| Dec 31, 2021 | -254.88 Mn |
| Sep 30, 2021 | -273.13 Mn |
| Jun 30, 2021 | -156.72 Mn |